Transforming Growth Factor beta
"Transforming Growth Factor beta" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A factor synthesized in a wide variety of tissues. It acts synergistically with TGF-alpha in inducing phenotypic transformation and can also act as a negative autocrine growth factor. TGF-beta has a potential role in embryonal development, cellular differentiation, hormone secretion, and immune function. TGF-beta is found mostly as homodimer forms of separate gene products TGF-beta1, TGF-beta2 or TGF-beta3. Heterodimers composed of TGF-beta1 and 2 (TGF-beta1.2) or of TGF-beta2 and 3 (TGF-beta2.3) have been isolated. The TGF-beta proteins are synthesized as precursor proteins.
Descriptor ID |
D016212
|
MeSH Number(s) |
D12.644.276.374.687 D12.644.276.954.775 D12.776.467.374.687 D12.776.467.942.775 D23.529.374.687 D23.529.942.775
|
Concept/Terms |
Transforming Growth Factor beta- Transforming Growth Factor beta
- Milk Growth Factor
- Factor, Milk Growth
- Growth Factor, Milk
- TGF-beta
- TGFbeta
- Platelet Transforming Growth Factor
- Bone-Derived Transforming Growth Factor
- Bone Derived Transforming Growth Factor
|
Below are MeSH descriptors whose meaning is more general than "Transforming Growth Factor beta".
Below are MeSH descriptors whose meaning is more specific than "Transforming Growth Factor beta".
This graph shows the total number of publications written about "Transforming Growth Factor beta" by people in this website by year, and whether "Transforming Growth Factor beta" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 3 | 1 | 4 |
1996 | 6 | 1 | 7 |
1997 | 3 | 1 | 4 |
1998 | 6 | 9 | 15 |
1999 | 7 | 5 | 12 |
2000 | 1 | 6 | 7 |
2001 | 7 | 0 | 7 |
2002 | 7 | 9 | 16 |
2003 | 5 | 3 | 8 |
2004 | 8 | 8 | 16 |
2005 | 7 | 4 | 11 |
2006 | 12 | 3 | 15 |
2007 | 8 | 7 | 15 |
2008 | 5 | 5 | 10 |
2009 | 2 | 5 | 7 |
2010 | 6 | 7 | 13 |
2011 | 4 | 7 | 11 |
2012 | 6 | 11 | 17 |
2013 | 6 | 8 | 14 |
2014 | 3 | 7 | 10 |
2015 | 7 | 3 | 10 |
2016 | 3 | 3 | 6 |
2017 | 7 | 3 | 10 |
2018 | 5 | 8 | 13 |
2019 | 5 | 8 | 13 |
2020 | 2 | 4 | 6 |
2021 | 3 | 1 | 4 |
2022 | 1 | 7 | 8 |
2023 | 2 | 3 | 5 |
2024 | 3 | 5 | 8 |
2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Transforming Growth Factor beta" by people in Profiles.
-
Integral Roles of the TGF? Signaling Pathway in Uterine Function and Disease. Endocrinology. 2025 Feb 05; 166(3).
-
Fibroblast-specific TGF-? signaling mediates cardiac dysfunction, fibrosis, and hypertrophy in obese diabetic mice. Cardiovasc Res. 2024 Dec 14; 120(16):2047-2063.
-
TGF-? trap of AdAPT-001 turns up the heat on tumors and turns down checkpoint blocker resistance. J Immunother Cancer. 2024 Oct 26; 12(10).
-
Mitral Annular Disjunction in Heritable Thoracic Aortic Disease: Insights From the Montalcino Aortic Consortium. J Am Heart Assoc. 2024 Nov 05; 13(21):e036274.
-
Dual optical elastography detects TGF-? -induced alterations in the biomechanical properties of skin scaffolds. J Biomed Opt. 2024 Sep; 29(9):095002.
-
BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AML. Sci Transl Med. 2024 Sep 11; 16(764):eadp0004.
-
Fibrotic response to anti-CSF-1R therapy potentiates glioblastoma recurrence. Cancer Cell. 2024 Sep 09; 42(9):1507-1527.e11.
-
GVHD targets organoid-forming bile duct stem cells in a TGF-?-dependent manner. Blood. 2024 08 22; 144(8):904-913.
-
Fibroblast Smad7 Induction Protects the Remodeling Pressure-Overloaded Heart. Circ Res. 2024 Jul 19; 135(3):453-469.
-
BIGH3 mediates apoptosis and gap junction failure in osteocytes during renal cell carcinoma bone metastasis progression. Cancer Lett. 2024 Aug 01; 596:217009.